Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation
Phase of Trial: Phase IV
Latest Information Update: 15 Feb 2016
At a glance
- Drugs Paliperidone (Primary) ; Lithium
- Indications Major depressive disorder; Suicidal ideation
- Focus Therapeutic Use
- Acronyms AFSP
- 28 Jan 2016 No of arms changed from 2 to 3 with change in dose range of Paliperidone (3-6 mg/day to 1-5 mg/day) and addition of placebo arm as per ClinicalTrials.gov record.
- 17 Mar 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 21 Mar 2012 New trial record